| Professional Services Industry | Industrials Sector | Mr. Kensuke Kondo CEO | XMUN Exchange | - ISIN |
| Japan Country | 4,513 Employees | 28 Mar 2025 Last Dividend | 29 Aug 2016 Last Split | - IPO Date |
BML, Inc., based in Tokyo, Japan since its incorporation in 1955, stands as a comprehensive provider of laboratory testing and related services. The company caters to the needs of the medical and pharmaceutical societies and organizations in Japan, offering an extensive array of laboratory testing spanning from biochemical and hematologic examinations to genetic studies. In addition to direct testing services, BML, Inc. is also at the forefront of developing innovative automation systems for laboratory processes and offers a wide spectrum of medical information system services. Their commitment extends beyond medical concerns, addressing environmental, food safety, and occupational health through an array of specialized testing services. Furthermore, BML, Inc. leverages its expertise to offer consulting services, supporting the pharmaceutical industry and enhancing preventive medicine approaches.
BML, Inc. provides comprehensive laboratory testing services, including biochemical and hematologic examinations, special laboratory tests such as RIA, cellular, immunological, DNA analysis, and microbiological tests for a wide range of medical purposes. The company also focuses on tumorology, infectious diseases, diabetes, hypertension, allergies, and genetic studies, supporting the medical community with essential diagnostic insights.
The Frontier and Symphony automation systems developed by BML revolutionize laboratory processes by automating the pre-processing procedures from sorting to dispensing, as well as the subsequent test procedures, thereby increasing efficiency and accuracy in laboratory operations.
BML offers medical information system services that include electronic medical charts, facilitating the networking of medical information and enhancing the efficiency of healthcare delivery, along with preventive medicine services.
The company provides food sanitation testing, encompassing control and processing services. These services include microorganism testing of raw materials, prepared and processed foods, environmental hygiene testing of food processing facilities and kitchens, and assessment of genetically modified organisms, ensuring food safety and compliance with health standards.
BML also offers drinking water and wastewater tests, work environment testing services, including the measurement of hazardous substances such as ethylene oxide gas, formaldehyde, organic solvents, and dust. Additionally, the company undertakes environmental monitoring to measure indoor contaminants and other environmental variables, along with biological dioxin monitoring services, contributing to the health and safety of both the public and workplace environments.
Apart from the core services, BML provides analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for pharmaceutical approvals; investigative analysis for pharmaceutical manufacturers; human genome analysis services; and gene expression analyses. These services expand BML's role in supporting disease prevention, diagnosis, and treatment, pharmaceutical development, and public health initiatives.